BusinessCell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other DiseasesBy Nasdaq OMXMar 15, 2017, 12:01 PM UTC
BusinessCell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other DiseasesBy Nasdaq OMXMar 15, 2017, 12:01 PM UTC
BusinessPeregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2017 and Recent DevelopmentsBy Nasdaq OMXMar 13, 2017, 8:05 PM UTC
BusinessPeregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred StockBy Nasdaq OMXMar 9, 2017, 9:05 PM UTC
BusinessGenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FISH TestsBy Nasdaq OMXMar 7, 2017, 2:00 PM UTC
BusinessCidara Therapeutics Reports Unfavorable Results of Phase 2 RADIANT Trial of CD101 Topical in VVCBy Nasdaq OMXFeb 21, 2017, 12:30 PM UTC
BusinessLonza and Selecta Biosciences Announce Manufacturing Agreement for Anc80-AAV-Based Gene Therapy for Treatment of Methylmalonic AcidemiaBy Nasdaq OMXFeb 16, 2017, 12:01 PM UTC
BusinessLonza and Selecta Biosciences Announce Manufacturing Agreement for Anc80-AAV-Based Gene Therapy for Treatment of Methylmalonic AcidemiaBy Nasdaq OMXFeb 16, 2017, 12:01 PM UTC
